In this study, RBAP, a plant‐derived TLR4‐targeting bioactive polypeptide, is found to inhibit the M1 polarization of microglia and promote their shift from M1 to M2 polarization, which thereby alleviates the neuroinflammation in AD. The gene discussed is TLR4; the disease is Alzheimer disease.